UPDATE: Cowen Starts Icosavax Inc. (ICVX) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
Jefferies Starts Icosavax Inc. (ICVX) at Buy
August 23, 2021 7:25 AM EDTJefferies analyst Kelechi Chikere initiates coverage on Icosavax Inc. (NASDAQ: ICVX) with a Buy rating and a price target of $50.00.
The analyst commented, "ICVX is developing a novel vaccine platform that can elicit broader, more durable neutralizing antibodies with a cleaner tolerability... More
William Blair Starts Icosavax Inc. (ICVX) at Outperform
August 23, 2021 4:03 AM EDTWilliam Blair analyst Andy Hsieh initiates coverage on Icosavax Inc. (NASDAQ: ICVX) with a Outperform rating.
For an analyst ratings summary and ratings history on Icosavax Inc. click here. For more ratings news on Icosavax Inc. click here.
Shares of Icosavax Inc. closed at $34.60 yesterday.
... More